The US Health and Human Services department has said that there is an increase in orders of Monoclonal antibodies in the past month as COVID cases continue to spike. It was found that more than 75% of Monoclonal antibodies order were coming from those regions which had lower vaccination rates.
Health and Human Services(HHS) have said many doctors are adopting the treatment known as MABs, and that this treatment is becoming popular among doctors. Though Federal Government had sent many doses of vaccines to the states it was not judiciously used because of complicated logistics.
Increase In Orders Of Monoclonal Antibodies To Treat COVID-19
Recently as per the data obtained on August 6th almost half of the vaccination supplies have been used. The vaccines were used in that location that had low vaccination rates. HHS spokesperson said currently lots of vaccinations are available for new sites and also existing sites. The vaccination ordering has been made smooth and sites can order vaccines needed for two weeks. From the start of the pandemic, nearly 600,000 people have been treated.
More than 203,000 patient courses have been ordered nationwide in the period of July 1st and August 5th. Florida, Mississippi Alabama, and many states of region 4 have ordered more than 81,000 vaccination courses. In Region 6, Texas, Louisiana, and New Mexico have ordered 77,000 vaccination courses.
Dr. Marcella Nunez Smith who is a senior advisor of the white house in matters of COVID-19 said that Monoclonal antibodies are working, they are found to be safe. They are free and are found to be effective against critical illness.
Nunez Smith has quoted the example of two Arizona antibody treatment sites that have been set up as a federal team. It was positive data obtained from Arizona because whoever got treated did not require hospitalization post the treatment. Smith confirmed that the federal government has surged shipments to Florida. The shipments have increased eight times over the past month.
Governor of Florida Ron De Santis said that in Jacksonville a rapid response unit will be set up for administering antibody treatments. This will be used as a model for strike teams to extend the facilities to long-term care facilities. Ron De Santis said that currently, this is the most effective treatment discovered for COVID which can prevent hospitalizations.
Monoclonal is found to be effective in preventing high-risk COVID symptoms. But undergoing an antibody treatment is not an easy task like gulping a pill. This treatment needs medical facilities and dedicated staff for administering it to patients.
For people of 12 years old and older the COVID-19 emergency, treatments have been authorized by Regeneron, GlaxoSmithKline, and Eli Lilly. Owing to the sudden spikes in COVID-19 HHS has been reaching out to states to help them with ease of access to vaccination. HHS has been actively providing technical assistance and is working for health systems to expand their antibody treatments.
In the past week, there was a considerable uptick in the antibody treatments as reported by Regeneron. Their initial estimation of people receiving mAbs was only 5% but it has gained an increase of 30% which is a big number. Till July 19th an average of 25 thousand doses were delivered per week and in past few weeks, it has been more than 60 thousand.
Previously in April, the US Food and Drug Administration had put a pause in the distribution of Eli Lily’s antibody treatment as it was not found to be effective against mutations and variants of Coronavirus. But it revoked the pause. In June HHS has paused the distribution of another treatment also another combination of two monoclonal antibodies as they were not effective against beta and gamma variants of Corona.